Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Register
Compounders on Capitol Hill 2-14
Share |

iacp's 20th annual compounders

on capitol hill



 


 

 


 

2014 Exhibitors & Sponsors10th Annual Rx Mixer
CCH 2014 Congressional Asks
Graphic Toolkit


CCH 2014 Report

 FAQs

CCH 2013 Report

CCH 2014 Photo Gallery

CCH 2012 Report

CCH 2013 Photo Gallery

CCH History

CCH 2012 Photo Gallery

CCH 2014 Newsletters

 CCH 2013 Newsletters

CCH Press Releases

 CE Credit Info Sheet



400 Attendees Convene in Washington, D.C. for the 20th Annual Compounders on Capitol Hill



The United Voice of Compounders Is Heard!

A special thanks to all the IACP members who participated either in person at Compounders on Capitol Hill, held, May 17-20, 2014 in Washington, D.C., or via our Virtual Hill Day -- your efforts made a HUGE impact. And a fast one as well. One of our key messages to Senators and Congressmen was that the U.S. Food and Drug Administration (FDA's) interpretation of the 2013 Drug Quality & Security Act (DQSA) appears to ignore Congressional intent. Despite repeated invitations from IACP to speak with our CCH conference attendees, everyone at the FDA was "unavailable" to attend and talk to those most impacted by the agency's activities... and that was noticed by Congress.

U.S. Senator Lamar Alexander (R-Tenn.) announced that, at his request, the Senate Appropriations Committee is directing the FDA to meet with doctors, patients, and pharmacists to discuss their concerns about implementation of the compounding legislation passed into law in November 2013.

“The purpose of the compounding law is to end confusion and improve communication so we can help prevent another tragic meningitis outbreak. If FDA isn’t sitting down with doctors, patients and pharmacists and communicating how it is implementing the law, then I will stay on FDA until it does.” – Lamar Alexander

Click here to read the U.S. Senate HELP Press Release.

IACP and its legislative team have worked tirelessly for the past several months emphasizing that FDA should be implementing DQSA according to congressional intent. This issue was the primary basis of our CCH 2014 Asks. Click here to review these Asks.

Click here to read the complete CCH 2014 Report.

Click here to view the CCH 2014 Photo Gallery.
Association Management Software Powered by YourMembership.com®  ::  Legal